Jump to content

Diethyltryptamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 19:55, 4 October 2016 (Updating {{infobox_drug}} (changes to verified and watched fields - updated 'UNII_Ref', 'CAS_number_Ref', 'Verifiedfields', 'Watchedfields') per Chem/infobox_drug validation (report errors or...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Diethyltryptamine
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • N,N-diethyl-2-(1H-indol-3-yl)ethan-2-amine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H20N2
Molar mass216.32 g/mol g·mol−1
3D model (JSmol)
Melting point169 to 171 °C (336 to 340 °F)
  • CCN(CC)CCC1=CNC2=C1C=CC=C2
  • InChI=1S/C14H20N2/c1-3-16(4-2)10-9-12-11-15-14-8-6-5-7-13(12)14/h5-8,11,15H,3-4,9-10H2,1-2H3 checkY
  • Key:LSSUMOWDTKZHHT-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

DET, also known under its chemical name N,N-diethyltryptamine and as T-9,[1] is a psychedelic drug closely related to DMT and 4-HO-DET. However, despite its structural similarity to DMT it is active orally around 50–100 mg without the aid of MAO inhibitors lasting about 2–4 hours.

Chemistry

DET is an analogue of the common tryptamine hallucinogen N,N-Dimethyltryptamine or DMT.

Pharmacology

The mechanism of action is thought to be serotonin receptor agonism, much like other classic psychedelics.[2]

DET is sometimes preferred over DMT because it can be taken orally, whereas DMT cannot. This is because the enzyme monoamine oxidase degrades DMT into an inactive compound before it is absorbed. To overcome this, it must be administered in a different manner, i.e. intravenously, intramuscularly, by inhalation, by insufflation, rectally, or ingested along with an inhibitor of monoamine oxidase. Because DET has ethyl groups attached to its nitrogen atom, monoamine oxidase is unable to degrade it. This is also true for many other tryptamines with larger nitrogen substituents.

Biochemistry

Although DET is a synthetic compound with no known natural sources, it has been used in conjunction with the mycelium of Psilocybe cubensis to produce the synthetic chemicals 4-PO-DET (Ethocybin) and 4-HO-DET (Ethocin), as opposed to the naturally occurring 4-PO-DMT (Psilocybin) and 4-HO-DMT (Psilocin). Isolation of the alkaloids resulted in 3.3% 4-HO-DET and 0.01-0.8% 4-PO-DET.[3]

Psychosis model

Early studies of DET as well as other psychedelics were mainly focused on the presumed psychotomimetic properties.[4] Researchers theorized that abnormal metabolites of endogenous chemicals such as tryptamine, serotonin, and tryptophan could be the explanation for mental disorders as schizophrenia, or psychosis.[5] With the progression of science and pharmacological understanding this belief has been dismissed by most researchers.

See also

References

  1. ^ "Erowid DET Vault : Chemistry". Retrieved 2008-01-08.
  2. ^ Winter JC (September 1969). "Behavioral effects of N,N-diethyltryptamine: absence of antagonism by xylamidine tosylate". J. Pharmacol. Exp. Ther. 169 (1): 7–16. PMID 5306645.
  3. ^ Gartz J (1989). "Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe". J. Basic Microbiol. 29 (6): 347–52. doi:10.1002/jobm.3620290608. PMID 2614674.
  4. ^ "PSILOCYBIN AND DIETHYLTRYPTAMINE: TWO TRYPTAMINE HALLUCINOGENS". Retrieved 2008-01-03.
  5. ^ "Effects of LSD-25, N,N-Dimethyltryptamine (DMT), and N,N-Diethyltryptamine (DET) on the Photic Evoked Responses in the unanesthetized Rabbit". Retrieved 2008-01-03.

Template:TiHKAL